Long-term observation reveals time-course-dependent characteristics of tumour vascularisation

European Journal of Cancer

Volumn 41, Issue 7, 2005, Pages 1073-1085

  Hansen Algenstaedt, Nils ^a   Joscheck, Claudia ^a   Schaefer, Christian ^a   Lamszus, Katrin ^a   Wolfram, Lars ^a   Biermann, Tanja ^a   Algenstaedt, Petra ^a   Brockmann, Marc A ^a   Heintz, Carsten ^b   Fiedler, Walter ^a   Rüther, Wolfgang ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Asklepios Klinik Harburg   (Germany)

Author keywords

Angiogenesis; Drug delivery; Intravital microscopy; Microcirculation

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; BONE MARROW CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PERFUSION; PERFUSION AND SUPERFUSION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SCID MOUSE; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION; TUMOR BLOOD FLOW; TUMOR CELL; TUMOR VASCULARIZATION;

EID: 20944440718     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.12.034     Document Type: Article

References (56)

1. N. Hansen-Algenstaedt, B.R. Stoll, and T.P. Padera Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy Cancer Res 60 16 2000 4556 4560
2. J.B. Wyckoff, J.G. Jones, and J.S. Condeelis A critical step in metastasis: in vivo analysis of intravasation at the primary tumor Cancer Res 60 9 2000 2504 2511
3. S. Paget The distribution of secondary growths in cancer of the breast Lancet 1 1889 571 573
4. S. Rockwell Oxygen delivery: implications for the biology and therapy of solid tumors Oncol Res 9 67 1997 383 390
5. R.K. Jain Delivery of novel therapeutic agents in tumors: physiological barriers and strategies J Natl Cancer I 81 8 1989 570 576
6. J. Folkman Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis New Engl J Med 333 26 1995 1757 1763
7. J.D. Hood, M. Bednarski, and R. Frausto Tumor regression by targeted gene delivery to the neovasculature Science 296 5577 2002 2404 2407
8. R.S. Herbst, K.R. Hess, and H.T. Tran Phase I study of recombinant human endostatin in patients with advanced solid tumors J Clin Oncol 20 18 2002 3792 3803
9. J.P. Thomas, R.Z. Arzoomanian, and D. Alberti Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors J Clin Oncol 21 2 2003 223 231
10. J.E. Tseng, B.S. Glisson, and F.R. Khuri Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck Cancer 92 9 2001 2364 2373
11. L. Hlatky, P. Hahnfeldt, and J. Folkman Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us JNCI Cancer Spectr 94 12 2002 883 893
12. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 6801 2000 249 257
13. G. Bergers, K. Javaherian, and K.M. Lo Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 284 5415 1999 808 812
14. R. Kerbel, and J. Folkman Clinical translation of angiogenesis inhibitors Nat Rev Cancer 2 10 2002 727 739
15. D.J. Chaplin, P.L. Olive, and R.E. Durand Intermittent blood flow in a murine tumor: radiobiological effects Cancer Res 47 2 1987 597 601
16. G. Helmlinger, F. Yuan, and M. Dellian Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation Nat Med 3 2 1997 177 182
17. B.A. Teicher Hypoxia and drug resistance Cancer Metast Rev 13 2 1994 139 168
18. J.R. Less, T.C. Skalak, and E.M. Sevick Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions Cancer Res 51 1 1991 265 273
19. J.R. Less, M.C. Posner, and T.C. Skalak Geometric resistance and microvascular network architecture of human colorectal carcinoma Microcirculation 4 1 1997 25 33
20. R.K. Jain Determinants of tumor blood flow: a review Cancer Res 48 10 1988 2641 2658
21. R.K. Jain The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors Microcirculation 4 1 1997 1 23
22. K.M. Schweitzer, P. Vicart, and C. Delouis Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells Lab Invest 76 1 1997 25 36
23. U. Duhrsen, T. Martinez, and G. Vohwinkel Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow Growth Factors 19 1 2001 1 17
24. F. Yuan, H.A. Salehi, and Y. Boucher Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows Cancer Res 54 17 1994 4564 4568
25. M. Leunig, F. Yuan, and M.D. Menger Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice Cancer Res 52 1992 6553 6560
26. P. Algenstaedt, C. Schaefer, and T. Biermann Microvascular alterations in diabetic mice correlate with level of hyperglycemia Diabetes 52 2 2003 542 549
27. H.H. Lipowsky, and B.W. Zweifach Applications of the "two-slit photometric technique to the measurement of microvascular volumetric flow rates Microvasc Res 15 1978 93 101
28. F. Yuan, M. Leunig, and S.K. Huang Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft Cancer Res 54 13 1994 3352 3356
29. D. Fukumura, H.A. Salehi, and B. Witwer Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain Cancer Res 55 21 1995 4824 4829
30. C. Heintz, G. Riepe, and L. Birken Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure? J Endovasc Ther 8 3 2001 248 253
31. R.K. Jain, L. Munn, and D. Fukumura dissecting tumor pathophysiology using intravital microscopy Nat Rev Cancer 2 2002 266 276
32. R.G. Bagley, J. Walter-Yohrling, and X. Cao Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells Cancer Res 63 18 2003 5866 5873
33. G. Bergers, and L.E. Benjamin Angiogenesis: tumorigenesis and the angiogenic switch Nat Rev Cancer 3 6 2003 401 410
34. W.L. Monsky, D. Fukumura, and T. Gohongi Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor Cancer Res 59 16 1999 4129 4135
35. F. Kallinowski, K.H. Schlenger, and S. Runkel Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts Cancer Res 49 14 1989 3759 3764
36. L.T. Baxter, and R.K. Jain Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism Microvasc Res 41 1 1991 5 23
37. N. Hansen-Algenstaedt, P. Algenstaedt, and A. Bottcher Bilaterally increased VEGF-levels in muscles during experimental unilateral callus distraction J Orthop Res 21 5 2003 805 812
38. A.C. Hartford, T. Gohongi, and D. Fukumura Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction Cancer Res 60 8 2000 2128 2131
39. H. Matsumoto, W.G. Ma, and T. Daikoku Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice J Biol Chem 277 32 2002 29260 29267
40. V. Chiarugi, L. Magnelli, and O. Gallo Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review Int J Mol Med 2 6 1998 715 719
41. J. Holash, P.C. Maisonpierre, and D. Compton Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 5422 1999 1994 1998
42. K.A. Keyes, L. Mann, and B. Teicher Site-dependent angiogenic cytokine production in human tumor xenografts Cytokine 21 2 2003 98 104
43. N. Weidner, and J. Folkman Tumoral vascularity as a prognostic factor in cancer Important Adv Oncol 1996 167 190
44. M. Borre, B.V. Offersen, and B. Nerstrom Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting Brit J Cancer 78 7 1998 940 944
45. M.A. Rubin, M. Buyyounouski, and E. Bagiella Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome Urology 53 3 1999 542 547
46. J.D. Chapman, E.L. Engelhardt, and C.C. Stobbe Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays Radiother Oncol 46 3 1998 229 237
47. P. Vaupel, H. Hutten, and G. Thews Critical diffusion ranges for oxygen and glucose in tumor tissue considering Michaelis-Menten kinetics Bibl Anat 13 1975 313 314
48. H. Hashizume, P. Baluk, and S. Morikawa Openings between defective endothelial cells explain tumor vessel leakiness Am J Pathol 156 4 2000 1363 1380
49. R.K. Jain The next frontier of molecular medicine: delivery of therapeutics Nat Med 4 6 1998 655 657
50. R.K. Jain, G.C. Koenig, and M. Dellian Leukocyte-endothelial adhesion and angiogenesis in tumors Cancer Metast Rev 15 2 1996 195 204
51. U.H. von Andrian, J.D. Chambers, and L.M. McEvoy Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo Proc Natl Acad Sci USA 88 17 1991 7538 7542
52. M.B. Lawrence, and T.A. Springer Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins Cell 65 5 1991 859 873
53. C. Semino, L. Martini, and P. Queirolo Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience Anticancer Res 19 6C 1999 5645 5649
54. P.M. Schiltz, L.D. Beutel, and S.K. Nayak Characterization of tumor-infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer J Immunother 20 5 1997 377 386
55. H. Irjala, M. Salmi, and K. Alanen Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium J Immunol 166 11 2001 6937 6943
56. D.S. Silberstein, D.D. Schoof, and M.L. Rodrick Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cells J Immunol 142 6 1989 2162 2167